PT  - JOURNAL ARTICLE
AU  - Harold L. Atkins
AU  - Suresh C. Srivastava
TI  - Radiopharmaceuticals for Bone Malignancy Therapy
DP  - 1998 Jun 01
TA  - Journal of Nuclear Medicine Technology
PG  - 80--83
VI  - 26
IP  - 2
4099  - http://tech.snmjournals.org/content/26/2/80.short
4100  - http://tech.snmjournals.org/content/26/2/80.full
SO  - J. Nucl. Med. Technol.1998 Jun 01; 26
AB  - Objective: This continuing education article reviews radionuclide bone therapy agents that are available commercially and introduces agents that are being evaluated for future use. Currently these agents are used to provide pain palliation from metastases to bone. Future applications may include adjuvant therapy to surgery or external beam treatment. After reading this paper, the reader should be able to: (a) describe the desirable characteristics of radionuclide bone therapy agents; (b) compare and contrast radiopharmaceuticals available for bone therapy; and (c) state the clinical applications of radionuclide bone therapy agents.